Cargando…
The RGS-RhoGEFs control the amplitude of YAP1 activation by serum
Actin-dependent mechanisms drive the nuclear translocation of Yap1 to enable its co-activation of transcription factors that induce pro-growth and survival programs. While Rho GTPases are necessary for the nuclear import of YAP1, the relevant Guanine Exchange Factors (GEFs) and GTPase Activating Pro...
Autores principales: | , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group UK
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7841162/ https://www.ncbi.nlm.nih.gov/pubmed/33504879 http://dx.doi.org/10.1038/s41598-021-82027-4 |
_version_ | 1783643743212011520 |
---|---|
author | Lane, Brandon S. Heller, Brigitte Hollenberg, Morley D. Wells, Clark D. |
author_facet | Lane, Brandon S. Heller, Brigitte Hollenberg, Morley D. Wells, Clark D. |
author_sort | Lane, Brandon S. |
collection | PubMed |
description | Actin-dependent mechanisms drive the nuclear translocation of Yap1 to enable its co-activation of transcription factors that induce pro-growth and survival programs. While Rho GTPases are necessary for the nuclear import of YAP1, the relevant Guanine Exchange Factors (GEFs) and GTPase Activating Proteins (GAPs) that connect this process to upstream signaling are not well defined. To this end, we measured the impact of expressing sixty-seven RhoGEFs and RhoGAPs on the YAP1 dependent activity of a TEAD element transcriptional reporter. Robust effects by all three members of the regulator of G-protein signaling (RGS) domain containing RhoGEFs (ArhGEF1, ArhGEF11 and ArhGEF12) prompted studies relating their known roles in serum signaling onto the regulation of Yap1. Under all conditions examined, ArhGEF12 preferentially mediated the activation of YAP1/TEAD by serum versus ArhGEF1 or ArhGEF11. Conversely, ArhGEF1 in multiple contexts inhibited both basal and serum elevated YAP1 activity through its GAP activity for Gα(13). The sensitivity of such inhibition to cellular density and to low states of serum signaling supports that ArhGEF1 is a context dependent regulator of YAP1. Taken together, the relative activities of the RGS-RhoGEFs were found to dictate the degree to which serum signaling promotes YAP1 activity. |
format | Online Article Text |
id | pubmed-7841162 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2021 |
publisher | Nature Publishing Group UK |
record_format | MEDLINE/PubMed |
spelling | pubmed-78411622021-01-29 The RGS-RhoGEFs control the amplitude of YAP1 activation by serum Lane, Brandon S. Heller, Brigitte Hollenberg, Morley D. Wells, Clark D. Sci Rep Article Actin-dependent mechanisms drive the nuclear translocation of Yap1 to enable its co-activation of transcription factors that induce pro-growth and survival programs. While Rho GTPases are necessary for the nuclear import of YAP1, the relevant Guanine Exchange Factors (GEFs) and GTPase Activating Proteins (GAPs) that connect this process to upstream signaling are not well defined. To this end, we measured the impact of expressing sixty-seven RhoGEFs and RhoGAPs on the YAP1 dependent activity of a TEAD element transcriptional reporter. Robust effects by all three members of the regulator of G-protein signaling (RGS) domain containing RhoGEFs (ArhGEF1, ArhGEF11 and ArhGEF12) prompted studies relating their known roles in serum signaling onto the regulation of Yap1. Under all conditions examined, ArhGEF12 preferentially mediated the activation of YAP1/TEAD by serum versus ArhGEF1 or ArhGEF11. Conversely, ArhGEF1 in multiple contexts inhibited both basal and serum elevated YAP1 activity through its GAP activity for Gα(13). The sensitivity of such inhibition to cellular density and to low states of serum signaling supports that ArhGEF1 is a context dependent regulator of YAP1. Taken together, the relative activities of the RGS-RhoGEFs were found to dictate the degree to which serum signaling promotes YAP1 activity. Nature Publishing Group UK 2021-01-27 /pmc/articles/PMC7841162/ /pubmed/33504879 http://dx.doi.org/10.1038/s41598-021-82027-4 Text en © The Author(s) 2021 Open Access This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/. |
spellingShingle | Article Lane, Brandon S. Heller, Brigitte Hollenberg, Morley D. Wells, Clark D. The RGS-RhoGEFs control the amplitude of YAP1 activation by serum |
title | The RGS-RhoGEFs control the amplitude of YAP1 activation by serum |
title_full | The RGS-RhoGEFs control the amplitude of YAP1 activation by serum |
title_fullStr | The RGS-RhoGEFs control the amplitude of YAP1 activation by serum |
title_full_unstemmed | The RGS-RhoGEFs control the amplitude of YAP1 activation by serum |
title_short | The RGS-RhoGEFs control the amplitude of YAP1 activation by serum |
title_sort | rgs-rhogefs control the amplitude of yap1 activation by serum |
topic | Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7841162/ https://www.ncbi.nlm.nih.gov/pubmed/33504879 http://dx.doi.org/10.1038/s41598-021-82027-4 |
work_keys_str_mv | AT lanebrandons thergsrhogefscontroltheamplitudeofyap1activationbyserum AT hellerbrigitte thergsrhogefscontroltheamplitudeofyap1activationbyserum AT hollenbergmorleyd thergsrhogefscontroltheamplitudeofyap1activationbyserum AT wellsclarkd thergsrhogefscontroltheamplitudeofyap1activationbyserum AT lanebrandons rgsrhogefscontroltheamplitudeofyap1activationbyserum AT hellerbrigitte rgsrhogefscontroltheamplitudeofyap1activationbyserum AT hollenbergmorleyd rgsrhogefscontroltheamplitudeofyap1activationbyserum AT wellsclarkd rgsrhogefscontroltheamplitudeofyap1activationbyserum |